Skip to main content

Mobile Main Navigation

About
Grants & Resources
Harvard Resources
Projects

Mobile Utility Navigation

Harvard Medical School

Menu

Utility Navigation

Harvard Medical School

Search

Main navigation

About
Grants & Resources
Harvard Resources
Projects

Q-FASTR Records

Filter Q-FASTR Records

Filter Records

Fiscal Year Awarded

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Funding Level

Emergency
Pilot
Development

Project Category

View as cards View as table101 Projects

A degrader approach to mechanism-based therapeutics in pulmonary arterial hypertension

Fiscal Year Awarded:

2026

Principal Investigator:

Advancing the development of HUWE1 inhibitors for cancer treatment

Fiscal Year Awarded:

2026

Principal Investigator:

Bacterial siderophores for accelerated mineral weathering and carbon sequestration in seawater

Fiscal Year Awarded:

2026

Principal Investigator:

Brain specific modulation of thyroid hormone levels

Fiscal Year Awarded:

2026

Principal Investigator:

Bernardo Sabatini

Development of a novel therapeutic to accelerate epithelial repair following viral respiratory infection

Fiscal Year Awarded:

2026

Principal Investigator:

Development of targeted ectodomain shedding molecules

Fiscal Year Awarded:

2026

Principal Investigator:

Stephen Blacklow

Enhanced dual-AAV gene delivery to treat hereditary deafness

Fiscal Year Awarded:

2026

Principal Investigator:

Enhancing regulatory T cell function for adoptive CAR Treg therapy to treat autoimmune disease

Fiscal Year Awarded:

2026

Principal Investigator:

Melanocortin 1 receptor agonists for preventing skin cancer

Fiscal Year Awarded:

2026

Principal Investigator:

Non-invasive theranostics for endometriosis

Fiscal Year Awarded:

2026

Principal Investigator:

Ulrich von Andrian

Potassium channel enhancers to treat pain and epilepsy

Fiscal Year Awarded:

2026

Principal Investigator:

Potassium channel inhibitors for symptomatic treatment of multiple sclerosis

Fiscal Year Awarded:

2026

Principal Investigator:

Precision modulation of IL-10 pathways via IL-10 receptor-targeted nanobodies

Fiscal Year Awarded:

2026

Principal Investigator:

Purification pipeline

Fiscal Year Awarded:

2026

Principal Investigator:

Michael Springer

Relaxin family peptide receptor 2 modulators as therapeutics

Fiscal Year Awarded:

2026

Principal Investigator:

Targeting a protein to promote remyelination

Fiscal Year Awarded:

2026

Principal Investigator:

Targeting Ecdysone signaling for control of disease vector and other insects

Fiscal Year Awarded:

2026

Principal Investigator:

Norbert Perrimon

Targeting novel negative regulators to improve CAR T cell therapy responses in solid tumors

Fiscal Year Awarded:

2026

Principal Investigator:

Targeting tau hyperphosphorylation to develop novel therapeutics for Alzheimer’s Disease and other tauopathies

Fiscal Year Awarded:

2026

Principal Investigator:

Therapeutic development of secreted peptides uncovered by Barcoded Ligand Sequencing

Fiscal Year Awarded:

2026

Principal Investigator:

Michael Greenberg

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Facebook linkedin instagram youtube

401 Park Drive
Suite 505
Boston, MA 02215
(617) 384-8500

Footer

Accessibility
Digital Accessibility

User account menu

Log in

© 2026 by the President and Fellows of Harvard College